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Twin-arginine-containing signal sequences mediate the transmembrane transport of folded proteins. The cognate twin-
arginine translocation (Tat) machinery of Escherichia coli consists of the membrane proteins TatA, TatB, and TatC.
Whereas Tat signal peptides are recognized by TatB and TatC, little is known about molecular contacts of the mature,
folded part of Tat precursor proteins. We have placed a photo-cross-linker into Tat substrates at sites predicted to be either
surface-exposed or hidden in the core of the folded proteins. On targeting of these variants to the Tat machinery of
membrane vesicles, all surface-exposed sites were found in close proximity to TatB. Correspondingly, incorporation of the
cross-linker into TatB revealed multiple precursor-binding sites in the predicted transmembrane and amphipathic helices
of TatB. Large adducts indicative of TatB oligomers contacting one precursor molecule were also obtained. Cross-linking
of Tat substrates to TatB required an intact twin-arginine signal peptide and disappeared upon transmembrane translo-
cation. Our collective data are consistent with TatB forming an oligomeric binding site that transiently accommodates
folded Tat precursors.
INTRODUCTION
The twin-arginine translocation (Tat) system transports pro-
teins in a fully folded conformation across membranes of
bacteria, archaea, and plant chloroplasts (recently reviewed
in Panahandeh et al., 2009). Proteins are targeted to the Tat
pathway by N-terminal signal sequences harboring the con-
served sequence motif S-R-R-x-F-L-K (Berks, 1996). The
transport is energized solely by the transmembrane H-
motive force (Mould et al., 1991; Cline et al., 1992; Bageshwar
and Musser, 2007). In Gram-negative bacteria and chloro-
plasts, the Tat system comprises the three essential mem-
brane proteins TatA, TatB, and TatC. Some bacteria also
express a paralogue of TatA named TatE. TatD, which is
expressed from the same operon as TatA, TatB, and TatC, is
a soluble protein (Wexler et al., 2000). Recent studies suggest
that it could be involved in the degradation of malfolded
FeS-containing Tat substrates (Matos et al., 2009). Although
a quality control system rejecting malfolded Tat substrates is
well documented (Sanders et al., 2001; DeLisa et al., 2003;
Matos et al., 2008; Panahandeh et al., 2008), folding is not a
prerequisite for being transported via the Tat pathway (Rof-
fey and Theg, 1996; Hynds et al., 1998; Cline and McCaffery,
2007; Richter et al., 2007).
TatC that is predicted to span the membrane six times
provides the primary recognition site for Tat signal peptides
(Cline and Mori, 2001; Alami et al., 2003; Gerard and Cline,
2006; Marrichi et al., 2008). The precise signal peptide-bind-
ing site of TatC has not yet been identiﬁed, but it seems that
the entire N-terminal half of TatC is involved in precursor
recognition (Holzapfel et al., 2007), with the ﬁrst cytosolic
loop of TatC being of particular importance (Kreutzenbeck
et al., 2007; Strauch and Georgiou, 2007).
TatA, much like TatB, consists of a single transmembrane
domain and one amphipathic helix most likely located on
the cytoplasmic leaﬂet of the membrane. Differently sized
homooligomeric complexes of TatA were described after
various in vitro and in vivo analyses (Barrett et al., 2005;
Gohlke et al., 2005; McDevitt et al., 2006; Greene et al., 2007).
Assembly of these TatA complexes, presumably originating
from tetrameric units, requires the presence of precursor and
TatBC (Mori and Cline, 2002; Dabney-Smith et al., 2006;
Leake et al., 2008; Ridder et al., 2009). Homooligomeric com-
plexes of TatA are consistent with the idea that TatA forms
a size-ﬁtting protein-conducting channel. However, sup-
porting data on translocation intermediates stalling near
TatA are scarce (Panahandeh et al., 2008). On the contrary,
one Tat substrate was in fact found arrested in a membrane
environment completely devoid of any Tat components
(Cline and McCaffery, 2007). In combination with the ﬁnd-
ing that exposure of hydrophobic side chains blocked Tat-
dependent transport (Richter et al., 2007), these data seem to
support a “membrane-weakening” function of TatA by
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4151which it would allow transmembrane passage next to mem-
brane lipids (Bru ¨ser and Sanders, 2003). Even more contro-
versial views are that TatA might undergo topology inver-
sion (Goufﬁ et al., 2004; Chan et al., 2007) or even function as
a soluble protein (Schreiber et al., 2006; Berthelmann et al.,
2008; Frielingsdorf et al., 2008).
Despite 25% sequence homology, TatB cannot function-
ally be replaced by TatA (Sargent et al., 1999). Discrete
mutations at the extreme N terminus of TatA, however,
render it bifunctional now being able to suppress a TatB
deﬁciency (Blaudeck et al., 2005; Barrett et al., 2007). This is
the natural situation in Gram-positive bacteria that only
possess TatAC-systems (Jongbloed et al., 2006). In E. coli,
however, TatB is necessary for the transport of all tested
natural Tat precursors. TatB forms 1:1 complexes with TatC
(Bolhuis et al., 2001) that associate into higher oligomeric
assemblies (McDevitt et al., 2005; Oates et al., 2005; Orriss et
al., 2007). Together with TatC, TatB is thus part of a receptor
complex for Tat precursors directly interacting with Tat
signal peptides (Alami et al., 2003; Kreutzenbeck et al., 2007;
Panahandeh et al., 2008). Several reports suggest that before
recognition by TatBC, a Tat precursor might ﬁrst bind to
membrane lipids (Hou et al., 2006; Shanmugham et al., 2006;
Bageshwar et al., 2009).
While previous studies on the interaction between Tat
precursors and the subunits of the Tat machinery were
largely restricted to the area of the signal sequence, we
wanted to analyze which contacts the folded mature do-
mains of Tat precursors would enter upon membrane tar-
geting. Unexpectedly we ﬁnd that the major binding site for
folded substrates is formed by TatB.
MATERIALS AND METHODS
Plasmids
The precursors of SufI and TorA-PhoA and their KK-mutants were expressed
from plasmids pKSMSufI-RR, pKSMSufI-KK (Alami et al., 2003) and
pET28aTorA-PhoA, pET28aTorA-PhoAKK (Panahandeh et al., 2008), respec-
tively. These plasmids also served as templates for the introduction of TAG
stop codons at different amino acid positions of the mature domains of SufI
and PhoA, and p8737 (Alami et al., 2002) for the insertion of stop codons into
tatB. PCR-based site-speciﬁc mutations were introduced using the Quick-
Change Site-directed Mutagenesis kit system (Stratagene). The individual
primer pairs used to introduce the amber stop codons are given in the
Supplemental Material. Plasmid pKSM717SufI, S26L, A27L, Q30L carrying
the indicated amino acid exchanges was constructed using pKSMSufI-RR as
template and the primers listed under Supplemental Material.
In Vitro Reactions
S-135 cell extracts were prepared either from E. coli strain SL119 (Lesley et
al., 1991) or Top10 (Invitrogen) transformed with plasmid pSup-BpaRS-
6TRN(D286R) (Ryu and Schultz, 2006) to express amber mutants of Tat precur-
sors. Cells were grown overnight in the presence of 10 g/ml tetracycline (SL119)
and 35 g/ml chloramphenicol (Top10, pSup-BpaRS-6TRN(D286R), respec-
tively, and were used to inoculate fresh medium without antibiotics at a 1:100
ratio. Cells were grown and S-135 cell extracts were prepared as described
(Moser et al., 2007).
Coupled transcription/translation of pSufI and pTorA-PhoA from plasmid
DNAs was performed as described (Moser et al., 2007). In case of pTorA-
PhoA, oxidizing conditions were provided by the addition of 5 mM oxidized
glutathione (GSSG) at the start of synthesis. Incorporation of Bpa was per-
formed as described (Panahandeh et al., 2008). For cross-linking and transport
experiments, membrane vesicles were added 10 min after starting the syn-
thesis reaction and incubated for 25 min at 37°C. To assay translocation of
precursors into INVs, samples were treated with proteinase K according to
ref. (Moser et al., 2007). Before UV-induced cross-linking (Panahandeh et al.,
2008), reactions were stopped with 0.4 mM puromycin (ﬁnal concentration)
for 5 min at 37°C.
To analyze translocation of membrane-bound precursor, pSufI was synthe-
sized in the presence of Tat-INV. INV were reisolated by centrifugation at
100,000 g for 30 min at 4°C and resuspended in buffer to give the same ionic
conditions as before with either no further additives or an ATP-regenerating
system (Moser et al., 2007). Incubation at 37°C for 30 min was followed by PK
treatment and UV irradiation.
To analyze membrane-binding independently of translocation, pSufI was
synthesized in the absence of INVs for 30 min. Reactions were stopped by
incubating samples for 5 min with puromycin. To deplete any residual ATP,
hexokinase and glucose were added at ﬁnal concentrations of 0.01 u/ml and
12 mM respectively, and samples were incubated for 10 min at 37°C. To then
allow membrane-binding of pSufI, samples were incubated with INV for 15
min at 37°C in the presence of 0.1 mM CCCP before PK treatment and UV
irradiation.
Immunoprecipitations were performed as described (Alami et al., 2003)
with some modiﬁcations. After the ﬁnal washing step, antigen-antibody
complexes were released from Protein A-Sepharose by shaking samples in
SDS-PAGE loading buffer (Moser et al., 2007) for 10 min at 37°C at 1400 rpm.
After centrifugation for 1 min at 16000  g, the supernatant was transferred
to a new reaction tube and incubated for 5 min at 95°C when immunopre-
cipitating TatA and TatB and for 10 min at 56°C when immunoprecipitating
TatC.
Preparation of Membrane Vesicles
Tat-INV were prepared as described previously (Moser et al., 2007) from E.
coli strain BL21(DE3)pLysS transformed with plasmid p8737 (Alami et al.,
2002). Tat genes were induced at OD600  0.5 with 1 mM isopropyl thio-ß-
d-galactopyranoside (IPTG).
Tat-INV containing TatB amber mutants were prepared from E. coli strain
BL21(DE3) transformed with plasmids pSup-BpaRS-6TRN(D286R) and p8737
carrying the individual tatB mutations. Tat genes were induced at OD600  0.5
with 1 mM IPTG. At the same time 1 mM Bpa was added from a 1M stock
solution made in 1 M NaOH. Preparation continued as described (Moser et al.,
2007), avoiding extensive exposure to day light.
Miscellaneous
Polyclonal antibodies against TatA, TatB, and TatC were raised in rabbits as
described (Alami et al., 2002; Alami et al., 2003). Immunoblotting was per-
formed using the Lumi-LightPlus Western Blotting Kit (Roche) following the
manufacturer’s instructions. SDS-PAGE was performed as described previ-
ously (Moser et al., 2007). Transport efﬁciencies were calculated using Image-
Quant 5.2 (GE Healthcare).
RESULTS
Site-Speciﬁc Introduction of a Photo-Cross-Linker into
the Mature Domains of Tat Precursor Proteins
To probe for signal sequence-independent contact sites be-
tween a Tat precursor protein and subunits of the Tat trans-
location apparatus, we introduced the UV-sensitive p-ben-
zoyl-derivative of phenylalanine (Bpa) into the mature part
of SufI. SufI (FtsP) is a cofactor-free natural Tat substrate of
E. coli (Tarry et al., 2009a) and has extensively been used for
in vivo as well as in vitro analyses of the Tat export pathway
in E. coli.
To incorporate the photo-cross-linker Bpa into SufI, amber
(TAG) stop codons were introduced at selected sites of the
sufI DNA. Based on the crystal structure of SufI (Tarry et al.,
2009a), we chose the six surface-exposed sites illustrated in
Figure 1A. Four of these positions (F49, F194, L328, and
M338) are all located on the outer circumference on one side
of SufI, whereas positions L368 and W441 lie at the opposite
pole of the globular protein. As controls we selected the four
positions, W140, W161, L233, and F261, for which the crystal
structure of SufI predicts a central location thus hiding Bpa
in the core of the molecule (Figure 1B).
The SufI amber mutants were expressed in a cell-free
transcription/translation system equipped with an amber-
speciﬁc suppressor tRNA and a cognate tRNA-synthetase
(Ryu and Schultz, 2006). Because this tRNA-synthetase
charges Bpa to the tRNAsup, amber codons are suppressed if
the in vitro translation is performed in the presence of Bpa.
This is illustrated in Figure 2A displaying radiolabeled
translation products by SDS-PAGE and phosphorimaging.
In the absence of Bpa (Bpa), prominent truncates of SufI
were obtained due to premature termination at the individ-
ual amber stop codons introduced. The only fragment that
was too short to be retained on the gel was that of the F49
mutant. In addition to the termination products, small
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even in the absence of added Bpa, suggesting some read-
through of the amber stop codons under these in vitro
conditions. In the presence of added Bpa, however, the
amounts of full-size pSufI had considerably increased for all
amber mutants, indicating suppression of the stop codons
by incorporation of Bpa (the same results were obtained for
the internal sufI mutants, not shown).
To test to what extent the mutations affected translocation
competence, transport of the pSufI variants into inside-out
inner membrane vesicles of E. coli (INV) was measured (for
experimental details see below Figure 3A). When compared
with wild-type pSufI, all of the mutants carrying Bpa on the
surface exhibited unimpaired translocation efﬁciencies. In
contrast, transport of two internal mutants (W161 and L233)
was markedly reduced suggesting a major destabilization of
SufI’s tertiary structure by Bpa at those locations.
The Predominant Interacting Partner of Folded SufI Is
TatB
We then synthesized the ten sufI mutants in vitro in the
presence of Bpa to allow for the incorporation of the photo-
cross-linker and, after addition of membrane vesicles, for the
interaction with the Tat apparatus. In the autoradiogram of
Figure 2C, the results obtained for the individual pSufI
variants are represented by three lanes each. Comparing
from left to right each ﬁrst and third lane (downward point-
ing arrows) reveals a UV-dependent appearance of multiple
radiolabeled bands that are bigger than pSufI. The majority
of these pSufI adducts were also obtained in the absence of
INV (compare each second and third lane). However, for the
surface-exposed Bpa variants F49 – W441 of pSufI, a small
number of speciﬁc adducts were seen only after addition of
INVs. The most prominent ones are those marked with an
asterisk migrating around the 75-kDa marker position. Less
prominent INV-speciﬁc adducts were smaller in mass and
were seen clearly only for four of the Bpa variants of pSufI
(dots).
To identify these INV-speciﬁc pSufI adducts, we per-
formed immunoprecipitation with antibodies against TatA,
TatB, and TatC. Figure 2D depicts the results for ﬁve of the
surface-exposed Bpa variants of pSufI. The dot-labeled pSufI
adducts were all recognized by anti-TatA antibodies. No
contacts to TatC were detected. However, by far the most
prominent cross-links were the asterisk-labeled ones that
were precipitated with antibodies directed against TatB. The
F49 variant not included in Figure 2D, had already previ-
ously been reported to cross-link to TatB (Alami et al., 2003).
Thus all six cross-linker positions that cover a considerable
surface area of the folded SufI (Figure 1A) were found in the
preferential proximity of TatB. Cross-linking was strictly
restricted to surface-exposed sites, because none of the four
internal Bpa-variants yielded any INV-speciﬁc cross-link
(Figure 2C, W140 – F261), nor did immunoprecipitation
reveal any signiﬁcant Tat-cross-reactive material (exempli-
ﬁed in Figure 2D for W140).
The ﬁve pSufI-TatB adducts displayed fairly different elec-
trophoretic mobilities (asterisk-labeled bands in Figures 2, C
and D). A possible explanation is different geometries of the
branched adducts that are expected to form as a result of
TatB cross-linking to distantly located contact sites on the
surface of folded SufI. Position-speciﬁc cross-links varying
in electrophoretic mobility have also been observed for Sec
precursors proteins and the chaperone Trigger factor (Eisner
et al., 2003).
To evaluate the functional relevance of the cross-linking of
folded SufI to TatB, we constructed and tested variants of
the SufI amber mutants that had the RR-motif replaced by
the transport-deﬁcient KK-pair. The results are shown in
Figure 2D for SufI(F194Bpa) directly displaying the RR- and
KK-variants on top of each other. The characteristic cross-
links (dot and asterisk) of the RR-percursor were not ob-
tained for the KK-mutant and no immunoreactive material
could be recovered, except for some diffuse TatA-cross-
reactive bands of higher molecular mass. These are contam-
inants recognized by our polyclonal antiserum, because they
were obtained even when the cross-linker was hidden in the
core of SufI (Figure 2D, right, W140Bpa). Thus the observed
contacts between a considerable surface area of mature SufI
and TatB require an intact Tat signal sequence to form and
therefore are likely to reﬂect functional interactions of the in
vitro synthesized pSufI with INVs. Because the contact sites
were restricted to surface-exposed residues of pSufI, it is
obvious that TatB interacted only with folded precursor
molecules.
Folded pSufI Transiently Contacts TatB before
Translocation
In the preceding experiments, interactions between pSufI
and TatB/TatA were monitored while pSufI was synthe-
sized in the presence of INVs (i.e., in conditions that would
allow both binding and translocation into the vesicles). To
assign the pSufI-TatB adducts to either of the two events, we
performed the cross-linking experiment with the Bpa vari-
ants F194 and L328 of pSufI in the presence of carbonyl
cyanide m-chlorophenyl-hydrazone (CCCP). CCCP dissi-
pates the PMF (proton-motive force) of the vesicles and
thereby abolishes Tat-dependent translocation into INVs but
Figure 1. Surface-exposed and internal amino acid
residues of SufI that were exchanged by the photo-
cross-linker benzoyl-phenylalanine. (A) Surface-ex-
posed residues of SufI. Structural data were taken
from Tarry et al. (2009a). (B) Internal residues W140,
W161, L233, and F261 of SufI.
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et al., 2002). Figure 3A depicts transport of pSufI into INV as
indicated by the conversion of pSufI to SufI and the appear-
ance of proteinase K (PK)-resistant pSufI and SufI species
(lanes 1, 2 and 9, 10). After addition of the uncoupler CCCP,
however, both signs of transport were missing for both
pSufI variants tested (lanes 5, 6 and 13, 14). Whereas the
cross-links to TatA (dot) also disappeared in the presence of
CCCP, those to TatB (asterisk) were still visible (compare
lanes 4–8 and 12–16). Consistent with a PMF-dependent
recruitment of TatA to TatBC (Mori and Cline, 2002; Alami
et al., 2003; Dabney-Smith et al., 2006), the pSufI-TatA ad-
ducts are therefore likely to represent later steps during
translocation, whereas the PMF-insensitive TatB cross-links
rather reﬂect a pretranslocational binding event. Because the
size of the TatB adducts did not change upon addition of
CCCP, which also abolishes signal sequence cleavage (com-
pare lanes 1–5 and 9–13), they are likely adducts of the
signal sequence-containing SufI precursor.
To examine whether the multiple contacts, observed be-
tween folded pSufI and TatB, reﬂected a functional interme-
diary stage of the Tat export process, we synthesized
pSufI(L328Bpa) in the presence of INV to allow for binding
and transport and then recovered the vesicles with the
bound precursor by ultracentrifugation. When the resus-
pended INVs were mock incubated in buffer solution fol-
lowed by treatment with PK, 17% of the INV-associated
SufI species turned out to be protease-protected (Figure 3B,
lanes 1 and 2). Most of this PK-protected SufI must have
originated from translocation into the vesicle lumen during
the initial period of synthesis, because no ATP was added
for reenergization to the isolated vesicles. UV irradiation of
these INVs revealed that 15% of the vesicle-associated
pSufI was present in the 75-kDa TatB adduct (lane 3). Incu-
Figure 2. On membrane-targeting, the sur-
face of pSufI is found predominantly in the
vicinity of TatB. (A) Codons of the sufI DNA
that specify the indicated amino acids were
mutated to amber stop codons. The resulting
DNAs were transcribed and translated in vitro
by an E. coli cell-free extract prepared from a
strain that expresses an amber suppressor
tRNA and the cognate Bpa-speciﬁc tRNA-syn-
thetase. Radiolabeled translation products were
separated by SDS-PAGE and are visualized by
Phosphorimaging. The electrophoretic mobili-
ties of molecular mass standards are indicated
on the left. In contrast to the approx. 50-kDa
wild-type (wt) precursor of SufI (pSuf), smaller
translation products were predominantly ex-
pressed from the amber mutant DNAs when
Bpa was missing. These smaller translation
products match the molecular masses expected
for premature termination at the individual am-
ber codons. The shortest fragment of 48 amino
acids was not retained by the polyacrylamide
gel used here. In addition to each premature
termination product, some full-size pSufI was
synthesized in the absence of Bpa, obviously
resulting from read-through of the mutant
mRNAs. Addition of Bpa led to a clear in-
crease in full-size pSufI of each variant, indi-
cating suppression of the amber codons by the
incorporation of the cross-linker Bpa. (B)
Wild-type pSufI and its indicated Bpa variants
were synthesized in vitro in the presence of
inside-out inner membrane vesicles, and the
transport efﬁciency of each mutant was ana-
lyzed as described in Materials and Methods.
Transport efﬁciency of wt-pSufI was set 100%.
(C) After synthesis of each indicated Bpa vari-
ant of pSufI in the presence or absence of
membrane vesicles (INV), samples were irra-
diated with UV light or mock-incubated be-
fore SDS-PAGE and Phosphorimaging. UV ir-
radiation led to numerous radiolabeled bands
larger in size than pSufI, only few of which
were speciﬁcally obtained in the presence of
INV (lanes marked with downward pointing
arrows). The most prominent of those photo-
adducts are labeled with asterisks and dots. Of notice, no membrane-speciﬁc adducts were obtained for SufI variants W140, W161, L233, F261
carrying Bpa in the interior of the folded structure. (D) The indicated Bpa variants of pSufI were synthesized in vitro in the presence of INVs.
Samples irradiated with UV light were either directly prepared for SDS-PAGE or only after coimmunoprecipitation with antibodies directed
against TatA, TatB, and TatC (Tat). Asterisk-labeled adducts are recognized by anti-TatB antibodies and dot-labeled ones by anti-TatA
antibodies. No Tat-speciﬁc adduct was observed for the internal W140 variant of pSufI, nor were any speciﬁc cross-links obtained with the
nonfunctional KK-precursor of SufI.
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regenerating system, however, changed the situation com-
pletely (lanes 4–6). Now virtually all of the SufI-TatB
adducts, which could be recovered from the mock-treated
INV, had vanished (lane 6), and concomitantly the amount
of SufI that was translocated into the PK-protected environ-
ment of the INVs had substantially increased (52%; lane 4).
These results therefore clearly indicate that the cross-links
observed between the surface of a folded Tat precursor and
TatB represent a temporary binding event that precedes
Tat-dependent translocation.
Site-Speciﬁc Introduction of a Photo-Cross-Linker into
TatB
The results presented so far would be consistent with TatB
functioning as a pretranslocational attachment site for a
folded Tat precursor. If so, the question arises where on TatB
the precursor-binding sites would be located. To address
this experimentally, we introduced the cross-linker Bpa now
into TatB rather than into the Tat precursor protein. Codons
specifying a total of nine amino acids were mutated to
amber stop codons. The selected amino acids (Figure 4A) are
located throughout the essential parts of TatB as known
from truncation analysis (Lee et al., 2002). Mutagenizing
PCR was performed on tatABCD templates contained in a
high expression plasmid. These constructs were transformed
into otherwise wild-type E. coli cells together with plasmid
pSup-BpaRS-6TRN(D286R) encoding the amber suppressor
tRNABpa and the cognate tRNA synthetase. When grown in
the presence of Bpa, transformants expressed full-size TatB
variants (not shown) indicating successful suppression of
the stop codons and incorporation of Bpa into TatB. All
membrane vesicles isolated from the tatB mutant strains
contained TatB levels comparable to that of the control strain
transformed with the wild-type tatABCD plasmid and were
active in pSufI translocation (see below and Supplemental
Figure).
Membrane-Targeting of a Tat Precursor Is Characterized
by Multiple Contacts with the Cytosolic Domains of TatB
The tatB mutant vesicles were then used in the same type of
in vitro assays shown in Figures 2 and 3, except that the
cross-linker was now present in the vesicles rather than in
the radiolabeled pSufI. Figure 4B shows that UV-irradiation
of Bpa placed in the three consecutive positions I36, W35,
G34 of the amphipathic helix of TatB yielded radiolabeled
(and hence pSufI-containing) adducts, which were recog-
nized by antibodies against TatB (asterisks). The intensity of
cross-linking dropped from position I36 over W35 to G34,
the adducts of which could only be detected by immuno-
precipitation (lane 12). These ﬁndings suggest that the pre-
dicted amphipathic helix of TatB is in fact in a helical con-
formation when contacting the substrate. Because Bpa is
virtually a spacer-less cross-linker, the weak adducts ob-
tained when it was moved around the perimeter of the
amphipathic helix most likely reﬂect some rotational mobil-
ity of the helix. Except for position I36, the other Bpa loca-
tions yielded double TatB adducts (see below).
To discriminate between mere molecular proximity and
functional binding, we tested cross-linking of the TatB
(I36Bpa) variant also to a KK-mutant precursor of SufI. As
shown in Figure 4C (lanes 1–6), no cross-linking of TatB to
pSufI carrying the inactive Tat signal sequence was ob-
served, suggesting that the interaction with TatB required a
previous proof of Tat compatibility. Moreover, interaction of
the amphipathic helix of TatB with pSufI did not simply
result from a stalling of precursor at the TatB(I36Bpa) vari-
ant, as could have been expected if the Ile-to-Bpa exchange
had impaired the ability of TatB to functionally interplay
with the Tat machinery. As shown by protease protection,
the TatB(I36Bpa)-INVs were, however, active in transloca-
tion of pSufI (Figure 4C, lane 7 and Supplemental Figure).
To determine more closely at which step of the Tat export
pathway the amphipathic helix of TatB came into contact to
pSufI, we performed synthesis of pSufI ﬁrst in the absence of
INVs, stopped translation with puromycin, and then de-
Figure 3. A Tat precursor interacts transiently with TatB before its
translocation. (A) The two indicated Bpa variants of pSufI were
synthesized in the presence of INV, one-half of each reaction con-
taining the uncoupler CCCP at 0.1 mM, the other half only the
solvent DMSO. Samples were either digested with Proteinase K
(PK) to visualize protease-resistant (i.e., translocated precursor and
mature forms of SufI) or otherwise irradiated with UV light. The
labeled photo-adducts are those identiﬁed in Figure 2. Whereas
CCCP completely blocks translocation of pSufI into INVs and also
abolishes cross-linking to TatA, the TatB adducts of pSufI were not
affected by the uncoupler. (B) After synthesis of pSufI in the pres-
ence of INV, vesicles were collected by centrifugation, resuspended,
and incubated in the absence or presence of an ATP regenerating
system (cf. Materials and Methods). The ATP-dependent increase in
translocation is paralleled by a loss of cross-linking to TatB.
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hexokinase and glucose before adding membranes together
with the uncoupler CCCP. As expected, no translocation of
pSufI occurred under these completely energy-deprived
conditions (Figure 4C, compare lanes 7 and 10). Neverthe-
less the 75-kDa adduct between pSufI and the TatB of the
deenergized INVs was formed (compare lanes 9 and 12),
indicating that it must result from the pretranslocational
binding of pSufI to the vesicles.
Bpa was also incorporated into residues L54 and L56 at
the end of the predicted amphipilic helix of TatB and further
distally at position L78 (cf. Figure 4A). Like the I36 – G34
mutants the more distal TatB variants yielded 75-kDa
adducts to pSufI that could be immunoprecipitated with
antibodies against TatB (Figure 4D, lanes 4 and 5; 7 and 9; 13
and 14). In addition, all three positions yielded bigger TatB
adducts (asterisks). One of them had an approximate mass
of 90 kDa, similar to what was found for TatB(W35Bpa) and
TatB(G34Bpa) (cf. Figure 4B, lanes 6 and 12). TatB(L54Bpa)
gave rise to even two additional adducts of 110 kDa and
130 kDa (Figure 4D, lane 4). To rule out that any of these
multiple adducts resulted from cross-linking of TatB to the
processed form of SufI, INVs containing the TatB(L78Bpa)
variant were also probed with a noncleavable mutant pre-
cursor of SufI (pSufI-SP). As shown in Figure 4D (lanes 15
– 19), the mutant precursor although virtually not being
processed (lanes 15 and 16) displays the same cross-linking
pattern as its wild-type counterpart (lanes 13, 14 and 18, 19).
Thus all these prominent cross-links are adducts to the
precursor of SufI. The 90-kDa adduct seems to be too small
to reﬂect two TatB monomers contacting one pSufI molecule
and in theory could originate from two distinct species of
pSufI resulting in differently branched adducts. In contrast,
the 110-kDa and 130-kDa adducts of the TatB(L54Bpa) vari-
ant (lanes 4, 5) by size are likely to represent complexes of
two to three TatB monomers with a single precursor. These
cross-links therefore seem to indicate an oligomeric struc-
ture of TatB, to which pSufI had been targeted. Similar to the
Figure 4. Incorporation of the cross-linker
Bpa into TatB reveals multiple contacts be-
tween an extended part of the molecule and
precursor proteins. (A) Model of TatB depict-
ing its predicted transmembrane and amphi-
pathic helices and the approximate positions
of Bpa. (B) In vitro synthesis of radiolabeled
pSufI in the presence of INVs containing the
indicated Bpa variants of TatB. UV-irradiation
yielded cross-links of varying intensities (as-
terisks) that were immunoprecipitated by anti-
TatB antibodies. Note the different intensities
by which the three positions on a helix turn of
TatB cross-link to pSufI. (C) In vitro synthesis
of radiolabeled pSufI in the presence of INVs
containing the I36Bpa variant of TatB. Cross-
linking was completely abolished if the signal
sequence of pSufI carried a KK-mutation of the
consensus RR-motif (lanes 1–6). Cross-linking
was unimpaired (lanes 7–12), if INVs were
added posttranslationally after depleting all
energy sources to prevent translocation into
INV (cf. Materials and Methods). Protease-pro-
tected SufI species shown in lane 7 demonstrate
the translocation activity of the TatB(I36Bpa)
variant and the lack of PK protection in lane 10
conﬁrms the successful depletion of energy. (D)
In vitro synthesis of radiolabeled pSufI in the
presence of INVs containing the indicated Bpa
variants of TatB. Note the adducts to TatB
(L54Bpa) larger than 100 kDa that likely contain
more than one TatB monomer. The origin of the
TatB-adduct running at 90 kDa is not clear. This
and the 75-kDa adduct were also obtained with
a noncleavable mutant of pSufI (pSufI-SP) in-
dicating that all cross-links were between TatB
and the precursor of SufI (lanes 15–19). Cross-
linking of TatB to pSufI occurred independently
of translocation (lanes 20–25). (E) In vitro syn-
thesis of radiolabeled pSufI in the presence of
INVs containing the indicated Bpa variants of
TatB reveals a position-dependent cross-linking
of the transmembrane helix of TatB to pSufI
(lanes 1–12). Note the high molecular mass ad-
duct to TatB(L9Bpa) indicative of a TatB oli-
gomer. Cross-linking of TatB to pSufI occurred
independently of translocation (lanes 13–18).
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TatB, the TatB variants depicted in Figure 4D were active in
translocation (lanes 2, 11 and 20 and Supplemental Figure)
and interacted with pSufI at a stage preceding the actual
translocation step, because they were not affected by de-
energizing the INVs (lanes 23–25). These results indicate that
during functional membrane-targeting of pSufI, a stretch of
at least 42 amino acids of the cytosolic domain of TatB comes
in close proximity to the Tat precursor.
The Transmembrane Helix of TatB Is Also in Contact
with a Bound Tat Precursor
An amino acid exchange in the N-terminal part of the trans-
membrane domain of TatB was found to suppress defective
Tat signal sequences (Kreutzenbeck et al., 2007), suggesting
functional interactions of the membrane domain of TatB and
Tat substrate proteins. We therefore also investigated TatB
variants that contained the cross-linker in the transmem-
brane helix of TatB (Figure 4E). Bpa at position 9 gave a clear
cross-link to pSufI (lane 2, asterisk). Cross-links became
weaker when Bpa was moved around the helix turn (lanes 6,
10) indicating that the face of the transmembrane helix en-
compassing residue Leu 9 is closest to the Tat substrate.
Interestingly, also TatB(L9Bpa) yielded an additional adduct
bigger than 100 kDa (lanes 4, 15, 18) again indicative of more
than one TatB monomer contacting one radioactively la-
beled pSufI. As summarized in lanes 13–18, the TatB(L9Bpa)
variant exhibited translocation activity (cf. also the Supple-
mental Figure), but formed cross-links with pSufI, even if
translocation was completely blocked (lanes 16–18). These
results would be consistent with both an interaction of the
transmembrane domain of TatB with the signal sequence of
SufI or with the folded SufI moiety, in which case the trans-
membrane helices of TatB would be part of a binding plat-
form for folded Tat precursors.
TorA-PhoA Displays the Same TatB Binding as pSufI
To see whether these ﬁndings could be conﬁrmed for a
second Tat precursor, we also analyzed TorA-PhoA, which
is a model Tat precursor consisting of the Tat signal se-
Figure 5. TorAPhoA shows the same interaction
with TatB as pSufI. (A) Surface-exposed residues I174,
W270, I329, and L467 of PhoA used for the incorpora-
tion of the cross-linker Bpa. Structural data were taken
from Wang et al., (2005). (B) The 55 kDa Tat precursor
protein TorA-PhoA carrying Bpa at the surface posi-
tion W270 (arrow) was synthesized in vitro with INVs
added as indicated. When irradiated with UV-light, a
major photo-cross-link (asterisk) was obtained that
was recognized by anti-TatB antibodies (TatB) and
was absent from reactions devoid of membranes (lane
6). It was completely digested by Proteinase K (PK)
(lane 3) in contrast to the PK-resistant translocated
TorA-PhoA species (arrowheads) and therefore not
membrane-protected. The three translocated species of
TorA-PhoA from top to bottom are precursor, mature
form and a translocation-arrested species (Panahandeh
et al., 2008). Solubilization of the INVs’ Tat machinery
by 1% Triton X-100 prevented formation of the TatB
adduct of TorA-PhoA (lane 5), whereas dissipation of
the PMF by CCCP did not (lane 8). (C) TorA-PhoA
(arrow) carrying Bpa at the surface position I329 was
synthesized in vitro in the presence of INVs, irradiated
with UV-light, and immunoprecipitated with antisera
against TatA, TatB, and TatC (lanes 1–5). The only
Tat-speciﬁc photo-adduct obtained was the one recog-
nized by anti-TatB antibodies (asterisk). Cross-linking
was completely abolished if the signal sequence of
TorA-PhoA carried a KK-mutation of the consensus
RR-motif (lanes 6–10). (D) Internal residues I99 and
V196 of PhoA used for the incorporation of Bpa. (E)
Comparison between the surface-exposed Bpa variant
I329 of TorA-PhoA and the internal variant I99. Lanes
1–4 illustrate that transport of TorA-PhoA into INV
proceeded only when TorA-PhoA was synthesized un-
der oxidizing conditions, which were achieved by the
addition of oxidized glutathione (GSSG). Transport is
indicated in lane 4 by the appearance of the PK-resis-
tant TorA-PhoA species speciﬁed in B (arrowheads). In
contrast to the internal Bpa variant I99, the surface-
exposed variant I329 formed adducts with TatB (aster-
isk) both under reducing and oxidizing conditions. (F)
Cross-linking of the transmembrane and amphipathic
helix of TatB to TorA-PhoA. The two TatB variants
L9Bpa and L54Bpa again yielded higher molecular
mass adducts (arrows). Cross-linking was observed
both under reducing and oxidizing conditions.
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part of PhoA (alkaline phosphatase) (DeLisa et al., 2003).
Four surface-exposed (Figure 5A, I174, W270, I329, and
L467) and two internal residues (Figure 5D, I99 and V196) of
the PhoA moiety were chosen for replacement by amber
stop codons and subsequent incorporation of the photo-
cross-linker Bpa. As exempliﬁed for one of the surface lo-
cated Bpa variants (Figure 5B, W270), UV-irradiation in the
presence of INVs again yielded one prominent adduct (lanes
2, 7, 8, asterisk) that could be immunoprecipitated with
anti-TatB antibodies (lane 4). It was absent from reactions
that did not contain vesicles (compare lanes 6 and 7). Dif-
ferent from the ﬁndings with pSufI, no visible cross-linking
of the Bpa mutants of TorA-PhoA to TatA was obtained
(exempliﬁed for the surface-exposed Bpa variant I329 in
Figure 5C, lane 3). Like pSufI, folded TorA-PhoA was found
close to TatB, only if it carried an intact RR-motif in its signal
sequence (Figure 5C, compare lanes 4 and 9).
Previous studies had shown that TorA-PhoA, which har-
bors four cysteines within its PhoA moiety, can only be
transported by the Tat machinery if oxidizing conditions
allow formation of two disulﬁde bonds (DeLisa et al., 2003;
Panahandeh et al., 2008). This is also shown in Figure 5E, in
which protease-protected species sequestered by the INVs
(lane 4, arrowheads) were only obtained when the TorA-
PhoA variants were synthesized in the presence of oxidized
glutathione (GSSG, compare lanes 2 and 4). Cross-links to
TatB were, however, obtained under both reducing and
oxidizing conditions (lanes 6 and 7). Neither in the reduced
nor in the oxidized conformation did internal Bpa variants
of TorA-PhoA cross-link to TatB (demonstrated for the I99
mutant, lanes 10–11) indicating again that TatB contacts
only the surface of folded Tat precursors.
We also tested whether the adducts between TatB and
vesicle-bound TorA-PhoA was accessible to externally
added PK. PK, while sparing the TorA-PhoA species that
were translocated into the membrane vesicles, completely
digested the adduct between TatB and TorA-PhoA (Figure
5B, compare lanes 2 and 3). This is consistent with TatB
forming an attachment site exposed on the membrane sur-
face. On the other hand, disrupting the vesicles by Triton
X-100 before irradiation abolished interaction with TatB
(Figure 5B, compare lanes 5 and 7), indicating that a mem-
brane-embedded Tat translocase was required for these pre-
cursor-TatB adducts to form. As with pSufI, TatB adducts of
TorA-PhoA were insensitive to CCCP (Figure 5B, compare
lanes 7 and 8).
TatB variants carrying the cross-linker either within the
transmembrane or the amphipathic helix were examined for
interaction also with TorA-PhoA. All three positions yielded
cross-links with radioactively labeled precursor (Figure 5F,
asterisk) that could be immunoprecipitated with anti-TatB
antiserum (lanes 3, 9, 10, 14, 15). Lack of disulﬁde bond
formation by omission of GSSG did not affect interaction of
TorA-PhoA with TatB (cf. lanes 7–10; 14, 15). Again, Bpa
incorporated at the positions L9 and L54 of TatB yielded
additional high-molecular-mass adducts (lanes 3 and 15,
arrows), which could correspond in size at least to a TatB
dimer plus one precursor molecule. Collectively, the results
summarized in Figure 5 conﬁrm that membrane targeting of
folded Tat precursors leads to multiple contacts with the
transmembrane and the amphipathic helices of TatB.
DISCUSSION
Previous studies revealed that the signal sequence of Tat
precursor proteins is primarily recognized by TatC. TatB
was found as a constituent of a TatBC receptor complex but
its function remained poorly characterized. We now show
that upon functionally targeting the Tat translocase, folded
Tat precursors become surrounded by TatB. Juxtaposition of
a folded Tat substrate and TatB requires an active RR-motif
but is independent of the PMF at the membrane. TatB prox-
imity is lost upon transmembrane transport of the precursor
indicating that it represents an intermediary binding step of
a Tat precursor before its translocation. Interaction with
TatB occurs at multiple contact sites along the predicted
transmembrane and amphipathic helices of TatB. Collec-
tively these data suggest that TatB assembles into an oligo-
meric binding site that is able to transiently accommodate
large parts of a folded Tat precursor.
Because no TatB interactions with sites hidden in the
folded Tat precursors were detected, the observed interac-
tions of TatB occurred only with folded precursors. There-
fore, TatB adducts obtained with TorA-PhoA under reduc-
ing conditions suggest that, although the two disulﬁde
bonds of PhoA could not form (Panahandeh et al., 2008), the
precursor was probably not completely unfolded. This con-
clusion was recently also drawn from results obtained with
truncated variants of TorA-PhoA (Maurer et al., 2009). Thus
it seems likely that the lack of two disulﬁde bonds in TorA-
PhoA either leads to only a local unfolding or to a generally
relaxed conformation with an enlarged surface area. This
would still allow reduced TorA-PhoA to bind to TatB, pro-
vided that TorA-PhoA contained an intact RR-motif for tar-
geting the Tat machinery. TatB-precursor interactions of the
type described here would then precede the clearance of
translocation-incompetent substrates.
Among the cross-linker positions tested, L9 and L54 of
TatB yielded additional adducts with both pSufI and TorA-
PhoA that were bigger than 1:1 precursor-TatB complexes
(Figures 4, D and E and 5F). Because in these experiments
the cross-linker was not incorporated into the precursor
molecules and otherwise we never observed any substantial
formation of SDS-resistant precursor dimers under our in
vitro conditions, the larger complexes that TatB(L9Bpa) and
TatB(L54Bpa) formed are likely homooligomeric TatB as-
Figure 6. Models of possible TatB-precursor interactions. (A) The
gray bar represents the lipid bilayer. Each TatC molecule is depicted
by six stippled transmembrane helices. Four TatB monomers are
shown (diagonally hatched cylinders) with their transmembrane
helices contacting one TatC protomer each (the front TatC subunit
has been omitted for clarity) and with their cytosolic amphipathic
helices encapsulating a folded Tat precursor (black ellipse). The
twin-arginine signal sequence () is represented by a black line.
Its contacts to TatB and TatC are speculative. The tetrameric nature
of the TatBC complex is based on previous ﬁndings (Lee et al., 2006),
but the model would easily accommodate higher order oligomeric
structures. (B) Two Tat precursor molecules simultaneously binding
to TatB as suggested by recent data (Tarry et al., 2009b; Ma and
Cline, 2010).
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adducts could contain two and three TatB monomers. Using
cysteine cross-linking, dimerization of TatB via its trans-
membrane and amphipathic helix has in fact recently been
demonstrated to occur (Lee et al., 2006).
Our combined ﬁndings would be compatible with models
depicted in Figure 6. A folded precursor is shown that has
been targeted to TatBC via its twin-arginine signal peptide.
The exact binding site(s) for the Tat signal sequence on TatC
and TatB are not known and the ones depicted in Figure 6
are therefore speculative. The models are further based on
the assumption that the TatBC receptor consists of four
TatBC protomers (for clarity not all stoichiometric TatC sub-
units are shown). A tetrameric TatBC assembly would be in
line with previous cysteine-based cross-linking studies (Lee
et al., 2006), but our results could also be explained by TatBC
assemblies of higher order, such as heptamers, that were
recently deduced from single particle electron microscopy of
isolated TatBC complexes (Tarry et al., 2009b). Positioning of
TatC on the periphery of the complex is consistent with a
previous cysteine cross-linking analysis of TatC (Punginelli
et al., 2007).
Using site-directed photo-cross-linking, TatB contact sites
were found distributed over the major part of the precur-
sors’ surfaces. These adducts generally appeared as major
distinct bands on SDS-PAGE representing substantial frac-
tions of the in vitro synthesized Tat precursors (cf. Figure
3B). This fact actually rules out that the multiple TatB con-
tact sites detected on the surfaces of Tat precursors each
result from a different orientation of a highly mobile Tat
precursor with respect to a single TatB monomer. Such a
situation would hardly lead to discrete and prominent ad-
ducts but would rather result in a background noise of
cross-links only. We therefore conclude that the multiple
contact sites identiﬁed both on the substrates and on TatB
rather reﬂect a static binding of Tat precursors to stable
oligomeric TatB assemblies. These could be realized by sev-
eral TatB monomers forming a cage-like structure around
the folded precursor as depicted in Figure 6A.
Recently, Ma and Cline provided experimental evidence
that the homologous Tat system of plant chloroplasts is able
to accommodate and collectively translocate dimers or even
tetramers of Tat precursors (Ma and Cline, 2010). The model
depicted in Figure 6B combines such a situation with the
contacts between precursor molecules and TatB that our
cross-linking approach revealed. Such a scenario might re-
quire a larger TatB assembly such as the heptameric arrays
of TatBC inferred from single particle analysis of isolated
TatBC complexes (Tarry et al., 2009b).
In principle, the observed cross-links between Tat precur-
sors and TatB could also be explained by an even more
speculative conformation, in which the amphipathic helices
of TatB cover the folded substrate only after having ﬂipped
across the bilayer. We, however, regard such a scenario less
likely (i) because in contrast to the topology-related TatA
protein (Goufﬁ et al., 2004; Chan et al., 2007) there is no
experimental evidence for such a movement of the amphi-
pathic helices of TatB, and (ii) if they did so, it would be at
high energy expenditure, which would be at odds with the
observation that the precursor-TatB adducts formed even
after dissipation of the PMF. Incorporated into all proposed
models is our ﬁnding that cross-linking from the amphi-
pathic helix of TatB was position-dependent thus indicating
that this precursor-interacting part of TatB in fact has a
helical conformation. Second, the calculated length of the
predicted amphipathic helix of TatB would be sufﬁcient to
cover the entire surface at least of one folded SufI molecule.
The model of Figure 6A could also illustrate how at a later
step the signal sequence is threaded into the TatBC complex
to stay in contact with TatC (Gerard and Cline, 2006) and
reach the far end of the TatB transmembrane helices as
suggested by tatB mutations of residue Glu 8 suppressing
defective signal sequences (Kreutzenbeck et al., 2007). How
the actual transmembrane transport of the folded substrate
domain could proceed from there, for example by recruiting
TatA protomers, remains to be solved. Nevertheless, a situ-
ation as depicted in Figure 6A would be fully compatible
with precursor molecules found attached to the periphery of
isolated TatBC complexes (Tarry et al., 2009b). Even the
changed dimensions of the membrane-embedded TatBC
complex observed upon precursor binding (Tarry et al.,
2009b) could be attributed to a movement of the TatB am-
phipathic helices from the surface of the complex to a cage-
like structure forming around a folded and targeted Tat
precursor.
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